Cambrex Corp (NYSE:CBM)

59.63
Delayed Data
As of Sep 13
 -0.09 / -0.15%
Today’s Change
33.80
Today|||52-Week Range
69.43
+57.92%
Year-to-Date

Today’s Trading

Previous close59.72
Today’s open59.82
Day’s range59.60 - 59.87
Volume380,161
Average volume (3 months)499,637
Market cap$2.0B
Data as of 6:30pm ET, 09/13/2019

Growth & Valuation

Earnings growth (last year)-11.37%
Earnings growth (this year)-30.40%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)-0.61%
P/E ratio37.0
Price/Sales2.39
Price/Book3.07

Competitors

 Today’s
change
Today’s
% change
BHVNBiohaven Pharmaceuti...+2.05+4.56%
AKCAAkcea Therapeutics I...-0.09-0.43%
ICPTIntercept Pharmaceut...+0.83+1.22%
APLSApellis Pharmaceutic...-1.20-4.26%
Data as of 6:30pm ET, 09/13/2019

Financials

Next reporting dateNovember 4, 2019
EPS forecast (this quarter)$0.45
Annual revenue (last year)$531.2M
Annual profit (last year)$92.4M
Net profit margin17.55%

Profile

Sector
Process Industries
Industry
Chemicals: Specialty
President, Chief Executive Officer &
Director
Steven M. Klosk
Chief Operating Officer &
Executive Vice President
Shawn P. Cavanagh
Corporate headquarters
East Rutherford, New Jersey

Forecasts